Lemoine, Jean
Ruella, Marco
Houot, Roch
Article History
Received: 24 August 2021
Accepted: 4 November 2021
First Online: 22 November 2021
Declarations
:
: Not applicable.
: Not applicable.
: JL has nothing to disclose. M.R. holds patents related to CAR T cells that are managed to the University of Pennsylvania and licensed to Novartis, Tmunity and viTToria biotherapeutics. M.R. has served as a consultant for nanoString, BMS, GSK, Bayer, and AbClon. M.R. receives research funding from AbClon, nanoString and Beckam Coulter. M.R. is the scientific founder of viTToria biotherapeutics. RH received honoraria from Bristol-Myers Squibb, MSD, Gilead, Kite, Roche, Novartis, Janssen, and Celgene.